{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:39:21Z","timestamp":1793162361015,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00266-020-01983-w","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T19:02:57Z","timestamp":1602615777000},"page":"1210-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-2799","authenticated-orcid":false,"given":"Nitin","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koenraad","family":"DeBoulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eqram","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"issue":"44","key":"1983_CR1","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1002\/anie.200705531","volume":"47","author":"B Willis","year":"2008","unstructured":"Willis B, Eubanks LM, Dickerson TJ, Janda KD (2008) The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison. Angew Chem Int Ed 47(44):8360\u20138679","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"1983_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clindermatol.2003.12.026","volume":"22","author":"AW Klein","year":"2004","unstructured":"Klein AW (2004) Contraindications and complications with the use of botulinum toxin. Clin Dermatol 22(1):66\u201375","journal-title":"Clin Dermatol"},{"key":"1983_CR3","unstructured":"Rohrer TE, Beer K (2005) Background to botulinum toxin. In: Carruthers A, Carruthers J, eds,\u00a0Botulinum Toxin, USA, Elsevier Inc, 9\u201318"},{"issue":"11","key":"1983_CR4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1524-4725.2011.02087.x","volume":"37","author":"AR Trindade de Almeida","year":"2011","unstructured":"Trindade de Almeida AR, Secco LC, Carruthers A (2011) Handling botulinum toxins: an updated literature review. Dermatol Surg 37(11):1553\u20131565","journal-title":"Dermatol Surg"},{"issue":"1","key":"1983_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsps.2016.04.024","volume":"25","author":"KH Awan","year":"2017","unstructured":"Awan KH (2017) The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions\u2014an evidence-based review. Saudi Pharm J 25(1):18\u201324","journal-title":"Saudi Pharm J"},{"key":"1983_CR6","first-page":"1","volume-title":"Botulinum toxin in aesthetic medicine","author":"B Rzany","year":"2007","unstructured":"Rzany B, Zielke H (2007) Overview of botulinum toxin. In: de Maio M, Rzany B (eds) Botulinum toxin in aesthetic medicine. Springer, Berlin, pp 1\u201310"},{"key":"1983_CR7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jancovic J (2004) Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 20:981\u2013990","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1983_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00266-002-1491-2","volume":"26","author":"MM Sposito","year":"2002","unstructured":"Sposito MM (2002) New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck. Aesth Plast Surg 26(2):89\u201398","journal-title":"Aesth Plast Surg"},{"issue":"1","key":"1983_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0039-6257(97)81995-9","volume":"41","author":"JJ Dutton","year":"1996","unstructured":"Dutton JJ (1996) Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Surv Ophthalmol 41(1):51\u201365","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"1983_CR10","first-page":"133","volume":"26","author":"JD Taylor","year":"1991","unstructured":"Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB (1991) Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol 26(3):133\u2013138","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"1983_CR11","first-page":"335","volume":"21","author":"HK Kalra","year":"1990","unstructured":"Kalra HK, Magoon EH (1990) Side effects of the use of botulinum toxin for the treatment of benign essential blepharospasm and hemifacial spasm. Ophthal Surg 21(5):335\u2013338","journal-title":"Ophthal Surg"},{"key":"1983_CR12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/mda.2001.25964","volume":"48","author":"AW Klein","year":"2002","unstructured":"Klein AW (2002) Complications and adverse reactions with the use of botulinum toxin. Dis Mon 48:336\u2013356","journal-title":"Dis Mon"},{"issue":"5","key":"1983_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1524-4725.1999.08286.x","volume":"25","author":"SC Huilgol","year":"1999","unstructured":"Huilgol SC, Carruthers A, Carruthers JD (1999) Raising eyebrows with botulinum toxin. Dermatol Surg 25(5):373\u2013376","journal-title":"Dermatol Surg"},{"issue":"2","key":"1983_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1526-4637.2005.05029.x","volume":"6","author":"S Omoigui","year":"2005","unstructured":"Omoigui S, Irene S (2005) Treatment of ptosis as a complication of botulinum toxin injection. Pain Med 6(2):149\u2013151","journal-title":"Pain Med"},{"issue":"6","key":"1983_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00266-004-0031-7","volume":"28","author":"MC Ferreira","year":"2004","unstructured":"Ferreira MC, Salles AG, Gimenez R, Soares MF (2004) Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases. Aesth Plast Surg 28(6):441\u2013444","journal-title":"Aesth Plast Surg"},{"issue":"3","key":"1983_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.59.3.418","volume":"59","author":"G Defazio","year":"2002","unstructured":"Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A (2002) Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicentre study. Arch Neurol 59(3):418\u2013420","journal-title":"Arch Neurol"},{"key":"1983_CR17","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1097\/00006534-200310001-00014","volume":"110","author":"A Matarasso","year":"2003","unstructured":"Matarasso A (2003) Discussion: new indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg 110:86S\u201387S","journal-title":"Plast Reconstr Surg"},{"key":"1983_CR18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00006534-200107000-00033","volume":"108","author":"SL Matarasso","year":"2001","unstructured":"Matarasso SL, Matarasso A (2001) Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytides. Plast Reconstr Surg 108:208\u2013214","journal-title":"Plast Reconstr Surg"},{"key":"1983_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/sder.2001.25964","volume":"20","author":"AW Klein","year":"2001","unstructured":"Klein AW (2001) Complications and adverse reactions with the use of botulinum toxin. Seminars Cut Med Surg 20:109\u2013120","journal-title":"Seminars Cut Med Surg"},{"key":"1983_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000370245","volume":"95","author":"E Yiannakopoulou","year":"2015","unstructured":"Yiannakopoulou E (2015) Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology 95:65\u201369","journal-title":"Pharmacology"},{"issue":"5","key":"1983_CR21","doi-asserted-by":"crossref","first-page":"NP102","DOI":"10.1093\/asj\/sju105","volume":"35","author":"MF Careta","year":"2015","unstructured":"Careta MF, Delgado L, Patriota R (2015) Report of allergic reaction after application of botulinum toxin. Aesthet Surg J 35(5):NP102\u2013NP105","journal-title":"Aesthet Surg J"},{"issue":"51","key":"1983_CR22","first-page":"545","volume":"37","author":"J Schlessinger","year":"2017","unstructured":"Schlessinger J, Gilbert E, Cohen J, Kaufman J (2017) New uses of abobotulinum toxin A in aesthetics. Aesth Surg J 37(51):545\u2013558","journal-title":"Aesth Surg J"},{"key":"1983_CR23","doi-asserted-by":"crossref","unstructured":"Bai L, Peng X, Liu Y, Sun Y, Wang X, Wang X, Lin G, Zhang P, Wan K, Qiu Z (2018) Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT). Medicine 97(34)","DOI":"10.1097\/MD.0000000000010659"},{"key":"1983_CR24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","volume":"46","author":"JA Carruthers","year":"2002","unstructured":"Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, Walker P, Eadie N, Group BG (2002) A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46:840\u2013849","journal-title":"J Am Acad Dermatol"},{"key":"1983_CR25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00042728-200504000-00007","volume":"31","author":"A Carruthers","year":"2005","unstructured":"Carruthers A, Carruthers J, Said S (2005) Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in female. Dermatol Surg 31:414\u2013422","journal-title":"Dermatol Surg"},{"key":"1983_CR26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1524-4725.2006.32325.x","volume":"33","author":"S Fagien","year":"2007","unstructured":"Fagien S, Cox SE, Finn JC, Werschler WP, Kowalski JW (2007) Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. Dermatol Surg 33:S2\u20139","journal-title":"Dermatol Surg"},{"key":"1983_CR27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00266-008-9199-6","volume":"32","author":"K Harii","year":"2008","unstructured":"Harii K, Kawashima M (2008) A double-blind, randomized, placebocontrolled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. Aesth Plast Surg 32:724\u2013730","journal-title":"Aesth Plast Surg"},{"key":"1983_CR28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1524-4725.2009.01390.x","volume":"36","author":"Y Wu","year":"2010","unstructured":"Wu Y, Zhao G, Li H, Zheng Z, Zhong S, Yang Z, Feng Z, Yang Q, Zhu X (2010) Botulinum toxin Type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study. Dermatol Surg 36:102\u2013108","journal-title":"Dermatol Surg"},{"key":"1983_CR29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1524-4725.2011.02024.x","volume":"37","author":"RA Dailey","year":"2011","unstructured":"Dailey RA, Philip A, Tardie G (2011) Long-term treatment of glabellar rhytides using onabotulinumtoxinA. Dermatol Surg 37:918\u2013928","journal-title":"Dermatol Surg"},{"key":"1983_CR30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/01.prs.0000279377.86280.8d","volume":"120","author":"MA Stotland","year":"2007","unstructured":"Stotland MA, Kowalski JW, Ray BB (2007) Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plast Reconstr Surg 120:1386\u20131393","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"1983_CR31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04071.x","volume":"48","author":"M Kawashima","year":"2009","unstructured":"Kawashima M, Harii K (2009) An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects. Int J Dermatol 48(7):768\u2013776","journal-title":"Int J Dermatol"},{"key":"1983_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","volume":"51","author":"B Ascher","year":"2004","unstructured":"Ascher B, Zakine B, Kestemont P, Baspeyras M, Bougara A, Santini J (2004) A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 51:223\u2013233","journal-title":"J Am Acad Dermatol"},{"key":"1983_CR33","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/j.1524-4725.2009.01235.x","volume":"35","author":"F Brandt","year":"2009","unstructured":"Brandt F, Swanson N, Baumann L, Huber B (2009) Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: efficacy and safety. Dermatol Surg 35:1893\u20131901","journal-title":"Dermatol Surg"},{"key":"1983_CR34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.asj.2009.09.003","volume":"29","author":"JL Cohen","year":"2009","unstructured":"Cohen JL, Schlessinger J, Cox SE, Lin X (2009) Reloxin Investigational Group. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesth Surg J 29:S43\u2013S49","journal-title":"Aesth Surg J"},{"key":"1983_CR35","first-page":"439","volume":"8","author":"MG Rubin","year":"2009","unstructured":"Rubin MG, Dover J, Glogau RG, Goldberg DJ (2009) The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol 8:439\u2013444","journal-title":"J Drugs Dermatol"},{"key":"1983_CR36","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","volume":"124","author":"MA Kane","year":"2009","unstructured":"Kane MA, Brandt F, Rohrich RJ, Narins RS, Monheit GD, Huber MB (2009) Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg 124:1619\u20131629","journal-title":"Plast Reconstr Surg"},{"key":"1983_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archfaci.2009.5","volume":"11","author":"R Moy","year":"2009","unstructured":"Moy R, Maas C, Monheit G, Huber MB (2009) Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Fac Plast Surg 11:77\u201383","journal-title":"Arch Fac Plast Surg"},{"key":"1983_CR38","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","volume":"33","author":"G Monheit","year":"2007","unstructured":"Monheit G, Carruthers A, Brandt F, Rand R (2007) A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 33:S51\u2013S59","journal-title":"Dermatol Surg"},{"key":"1983_CR39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.142.3.320","volume":"142","author":"B Rzany","year":"2006","unstructured":"Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W (2006) Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 142:320\u2013326","journal-title":"Arch Dermatol"},{"key":"1983_CR40","first-page":"28","volume":"4","author":"M Imhof","year":"2011","unstructured":"Imhof M, Keuhne U (2011) A phase III study of incobotulinumtoxinA in the treatment of glabellar frown lines. J Clin Aesthet Dermatol 4:28\u201334","journal-title":"J Clin Aesthet Dermatol"},{"key":"1983_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00042728-200503000-00001","volume":"31","author":"NJ Lowe","year":"2005","unstructured":"Lowe NJ, Ascher B, Heckman M, Kumar C, Fraczek S, Eadie N (2005) Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow\u2019s feet. Dermatol Surg 31:257\u2013262","journal-title":"Dermatol Surg"},{"key":"1983_CR42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","volume":"47","author":"NJ Lowe","year":"2002","unstructured":"Lowe NJ, Lask G, Yamauchi P, Moore D (2002) Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow\u2019s feet. J Am Acad Dermatol 47:834\u2013840","journal-title":"J Am Acad Dermatol"},{"key":"1983_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/14764170410028997","volume":"6","author":"JL Levy","year":"2004","unstructured":"Levy JL, Servant JJ, Jouve E (2004) Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow\u2019s feet wrinkle formation study. J Cosmet Laser Ther 6:16\u201320","journal-title":"J Cosmet Laser Ther"},{"key":"1983_CR44","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1524-4725.2009.01261.x","volume":"35","author":"B Ascher","year":"2009","unstructured":"Ascher B, Rzany BJ, Grover R (2009) Efficacy and safety of botulinum toxin type A in the treatment of lateral crow\u2019s feet: a double-blind, placebo-controlled, dose-ranging study. Dermatol Surg 35:1478\u20131486","journal-title":"Dermatol Surg"},{"key":"1983_CR45","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4725.2006.32326.x","volume":"33","author":"J Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A (2007) Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg 33:S10\u2013S17","journal-title":"Dermatol Surg"},{"key":"1983_CR46","first-page":"461","volume":"29","author":"A Carruthers","year":"2003","unstructured":"Carruthers A, Carruthers J, Cohen J (2003) A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg 29:461\u2013467","journal-title":"Dermatol Surg"},{"key":"1983_CR47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaad.2009.01.005","volume":"60","author":"A Carruthers","year":"2009","unstructured":"Carruthers A, Carruthers J (2009) A single-centre, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy. J Am Acad Dermatol 60:972\u2013979","journal-title":"J Am Acad Dermatol"},{"key":"1983_CR48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00266-002-2047-1","volume":"26","author":"NW Bulstrode","year":"2002","unstructured":"Bulstrode NW, Grobbelaar AO (2002) Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesth Plast Surg 26:356\u2013359","journal-title":"Aesth Plast Surg"},{"issue":"2","key":"1983_CR49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1473-2165.2005.40207.x","volume":"4","author":"PJ Bowler","year":"2005","unstructured":"Bowler PJ (2005) A retrospective study in the use of botulinum toxin type-A in a UK multidisciplinary cosmetic practice. J Cosmet Dermatol 4(2):89\u201392","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1983_CR50","first-page":"567","volume":"33","author":"A Carruthers","year":"2007","unstructured":"Carruthers A, Bogle M, Carruthers JD, Dover JS, Dover JS, Arndt KA, Hsu TS, Poirier J (2007) A randomized, evaluator-blinded, two-centre study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides. Dermatol Surg 33(5):567\u2013571","journal-title":"Dermatol Surg"},{"key":"1983_CR51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2230.2009.03607.x","volume":"35","author":"F Ghalamkarpour","year":"2010","unstructured":"Ghalamkarpour F, Robati RM, Aryanejad F, Toossi P (2010) Supraciliary wrinkles and botulinum toxin A. Clin Exp Dermatol 35:388\u2013391","journal-title":"Clin Exp Dermatol"},{"key":"1983_CR52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1473-2165.2007.00325.x","volume":"6","author":"MR Farahvash","year":"2007","unstructured":"Farahvash MR, Arad S (2007) Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. J Cosmet Dermatol 6:152\u2013158","journal-title":"J Cosmet Dermatol"},{"key":"1983_CR53","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1524-4725.2006.32327.x","volume":"33","author":"B Rzany","year":"2007","unstructured":"Rzany B, Dill-Mculler D, Grablowitz D, Heckmann M (2007) Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg 33:S18\u201325","journal-title":"Dermatol Surg"},{"key":"1983_CR54","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1524-4725.2010.01705.x","volume":"36","author":"A Carruthers","year":"2010","unstructured":"Carruthers A, Carruthers J, Monheit GD, Davis PG (2010) Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg\/mL smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Dermatol Surg 36:2121\u20132134","journal-title":"Dermatol Surg"},{"key":"1983_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.asj.2008.03.003","volume":"28","author":"S Liew","year":"2008","unstructured":"Liew S, Dart A (2008) Nonsurgical reshaping of the lower face. Aesth Surg J 28:251\u2013257","journal-title":"Aesth Surg J"},{"key":"1983_CR56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1473-2165.2008.00391.x","volume":"7","author":"A Redaelli","year":"2008","unstructured":"Redaelli A (2008) Medical rhinoplasty with hyaluronic acid and botulinum toxin A: a very simple and quite effective technique. J Cosmet Dermatol 7:210\u2013220","journal-title":"J Cosmet Dermatol"},{"key":"1983_CR57","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jaad.2010.02.053","volume":"63","author":"R Mazzuco","year":"2010","unstructured":"Mazzuco R, Hexsel D (2010) Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. J Am Acad Dermatol 63:1042\u20131051","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1983_CR58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/asj\/sjz174","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Cai L, Yang M, Li F, Han X (2020) Botulinum toxin to treat horizontal forehead lines: a refined injection pattern accommodating the lower frontalis. Aesth Surg J 40(6):668\u2013678","journal-title":"Aesth Surg J"},{"issue":"3","key":"1983_CR59","doi-asserted-by":"crossref","first-page":"e2669","DOI":"10.1097\/GOX.0000000000002669","volume":"8","author":"K De Boulle","year":"2020","unstructured":"De Boulle K, Carruthers A, Solish N, Carruthers J, Phillipp-Dormston WG, Fagien S, Sangha S, Silberberg M, Mao C (2020) OnabotulinumtoxinA treatment for moderate to severe forehead lines: a review. Plast Reconstr Surg-Glob Open 8(3):e2669","journal-title":"Plast Reconstr Surg-Glob Open"},{"issue":"4","key":"1983_CR60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1064-7406(03)00073-7","volume":"11","author":"SM Lam","year":"2003","unstructured":"Lam SM (2003) The basic science of botulinum toxin. Fac Plast Surg Clin N Am 11(4):431\u2013438","journal-title":"Fac Plast Surg Clin N Am"},{"key":"1983_CR61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mjd.2001.118342","volume":"46","author":"M Alam","year":"2002","unstructured":"Alam M, Arndt KA, Dover JS (2002) Severe, intractable headache after injection with botulinum A exotoxin: report of 5 cases. J Am Acad Dermatol 46:62\u201365","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1983_CR62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1524-4725.1998.tb04103.x","volume":"24","author":"FS Brandt","year":"1998","unstructured":"Brandt FS, Bellman B (1998) Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 24(11):1232\u20131234","journal-title":"Dermatol Surg"}],"updated-by":[{"DOI":"10.1007\/s00266-021-02659-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000}}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-020-01983-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-020-01983-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-020-01983-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T18:26:08Z","timestamp":1638210368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-020-01983-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1007\/s00266-020-01983-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00266-021-02659-9","asserted-by":"object"}]},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00266-021-02659-9","URL":"https:\/\/doi.org\/10.1007\/s00266-021-02659-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nitin Sethi: Allergan Consultant, on the speakers' board and a Key opinion leader. Sukhbir Singh: Allergan Consultant, on the speakers' board and a Key opinion leader. Koenraad DeBoulle: Allergan consultant, on the speakers' board, received grants for studies and educational events. Eqram Rahman: No Conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The necessary written informed consent for the images used in this paper is available with the authors and can be provided if required. All guidelines based on the declaration of Helsinki were followed while collecting and reproducing these images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}